Literature DB >> 3142597

Recurrent early miscarriage and polycystic ovaries.

M Sagle1, K Bishop, N Ridley, F M Alexander, M Michel, R C Bonney, R W Beard, S Franks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3142597      PMCID： PMC1834825          DOI： 10.1136/bmj.297.6655.1027

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

Authors:  J Adams; D W Polson; S Franks
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

2.  Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells.

Authors:  J F Mowbray; C Gibbings; H Liddell; P W Reginald; J L Underwood; R W Beard
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

3.  Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.

Authors:  R Homburg; N A Armar; A Eshel; J Adams; H S Jacobs
Journal:  BMJ       Date:  1988-10-22

4.  Polycystic ovaries--a common finding in normal women.

Authors:  D W Polson; J Adams; J Wadsworth; S Franks
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321
  4 in total
  23 in total

1.  Recurrent miscarriage.

Authors:  L Regan
Journal:  BMJ       Date:  1991-03-09

2.  Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.

Authors:  T T Piltonen; J Chen; D W Erikson; T L B Spitzer; F Barragan; J T Rabban; H Huddleston; J C Irwin; L C Giudice
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

Review 3.  The impact of obesity on egg quality.

Authors:  Scott H Purcell; Kelle H Moley
Journal:  J Assist Reprod Genet       Date:  2011-05-28       Impact factor: 3.412

Review 4.  Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles.

Authors:  Antonina I Frolova; Kelle H Moley
Journal:  Reproduction       Date:  2011-06-03       Impact factor: 3.906

5.  The clinical ramifications of polycystic ovarian morphology in oocyte donors.

Authors:  M Cho; G Ambartsumyan; H Danzer; K Brennan; M Surrey
Journal:  J Assist Reprod Genet       Date:  2013-01-05       Impact factor: 3.412

6.  Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

Authors:  Jin Yeong Kim; Haengseok Song; Hyunjoo Kim; Hee Jung Kang; Jin Hyun Jun; Sung Ran Hong; Mi Kyoung Koong; In Sun Kim
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

7.  Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.

Authors:  K Clifford; R Rai; H Watson; S Franks; L Regan
Journal:  BMJ       Date:  1996-06-15

8.  Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

Authors:  S West; H Lashen; A Bloigu; S Franks; K Puukka; A Ruokonen; M-R Järvelin; J S Tapanainen; L Morin-Papunen
Journal:  Hum Reprod       Date:  2014-08-01       Impact factor: 6.918

9.  DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism in mice.

Authors:  Patricia T Jimenez; Antonina I Frolova; Maggie M Chi; Natalia M Grindler; Alexandra R Willcockson; Kasey A Reynolds; Quihong Zhao; Kelle H Moley
Journal:  Endocrinology       Date:  2013-09-13       Impact factor: 4.736

Review 10.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.